Jack Nathan Medical Corp. (JNHMF) Comparison with companies in other sectors?

Jack Nathan Medical Corp. has a share price of 84.37M. You can analyze Jack Nathan Medical Corp. (JNHMF) competitors across different market sectors through stock heatmaps.

What are JNHMF's NET and operating margins?

Jack Nathan Medical Corp. (JNHMF) operating margin is around -0.37, and net profit margin is approximately -0.40 as of the latest reports.

In what way does JNHMF's earnings per share (EPS) trend reflect its financial momentum?

Jack Nathan Medical Corp. (JNHMF) EPS is -0.06 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Jack Nathan Medical Corp. is -0.06, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Jack Nathan Medical Corp.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Jack Nathan Medical Corp. like P/E which is -0.07, P/B which is -0.04, and PEG which is 0.005. Compare them with sector averages to evaluate if the stock is priced fairly.

Jack Nathan Medical Corp.

JNHMF•PNK

Healthcare

Medical - Care Facilities

$0.004

$0.00(8.11%)

Fundamental Analysis of Jack Nathan Medical Corp. (JNHMF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.06

P/E Ratio

-0.06

ROE

0.81%

Net Margin

-0.40%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$303.72K

Shares OutstandingTotal number of shares issued

$84.37M

Book Value/ShareNet worth per share

$-0.12

Revenue/ShareAnnual revenue per share

$0.18

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.06

Net MarginNet income as percentage of revenue

-40.41%

Operating MarginOperating income as percentage of revenue

-37.21%

ROEReturn on shareholders' equity

81.32%

ROAReturn on total assets

-91.98%

ROCEReturn on capital employed

-402.30%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.05

Cash/ShareCash and equivalents per share

$0.009

FCF YieldFree cash flow as percentage of market cap

-996.09%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for JNHMFFinancial Ratios Analysis details for JNHMF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for JNHMFSector Benchmarking details for JNHMF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Jack Nathan Medical Corp. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Jack Nathan Medical Corp.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Jack Nathan Medical Corp.'s unique business strengths and challenges.

Key Financial Metrics for Jack Nathan Medical Corp.

For Jack Nathan Medical Corp., essential financial indicators include EPS -0.06, PE -0.06, and ROE 0.81. These key ratios reveal insights into Jack Nathan Medical Corp.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Jack Nathan Medical Corp. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Jack Nathan Medical Corp.

Metrics like Net Margin -40.41% and ROA -91.98% shed light on how well Jack Nathan Medical Corp. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Jack Nathan Medical Corp. can sustain its operations and continue growing in the future.

Valuation and Market Position of Jack Nathan Medical Corp.

Using ratios such as P/B Ratio -0.04 and PEG Ratio 0.005, investors can assess whether Jack Nathan Medical Corp. is appropriately valued based on its financials and growth potential. These figures, combined with Jack Nathan Medical Corp.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Jack Nathan Medical Corp.

Financial health indicators, such as Debt/Equity Ratio -1.28 and Cash Flow $-0.05, provide a snapshot of Jack Nathan Medical Corp.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Jack Nathan Medical Corp., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Jack Nathan Medical Corp.

Investing in Jack Nathan Medical Corp. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Jack Nathan Medical Corp. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;